What Is Embolization and How Does the Procedure Work?

Embolization is a minimally invasive procedure in which a doctor deliberately blocks one or more blood vessels by threading a thin catheter through the vascular system and delivering materials that plug the target vessel from the inside. It is used to stop bleeding, starve tumors of their blood supply, and shrink abnormal tissue without open surgery. The technique has grown into one of the most versatile tools in interventional radiology, applied everywhere from emergency trauma rooms to elective treatment of uterine fibroids and enlarged prostates.

How the Procedure Works

The basic sequence is straightforward. An interventional radiologist punctures an artery, usually in the wrist or the groin, and inserts a catheter, a flexible tube roughly the diameter of a strand of spaghetti. Using real-time X-ray imaging called fluoroscopy, the catheter is guided through the arterial network until it reaches the vessel feeding the problem area. Contrast dye is injected so the blood vessels light up on screen, confirming the catheter is in the right place. Then the embolic material, whatever substance will create the blockage, is delivered through the catheter directly into the target vessel.

You stay awake for most embolization procedures, under moderate sedation and local anesthesia at the puncture site. General anesthesia is reserved for more complex cases such as certain brain procedures. Because there is no surgical incision beyond a small nick in the skin, the procedure typically takes one to three hours depending on how many vessels need treatment and how intricate the anatomy is.

What Actually Blocks the Vessel

The materials used for embolization fall into a few broad categories, and the choice depends on whether the goal is a permanent or temporary blockage, how large the target vessel is, and how precisely the material needs to be placed.

Particles and microspheres: Tiny beads made from materials like polyvinyl alcohol (PVA) or tris-acryl gelatin are injected through the catheter and wedge into small vessels downstream. They come in calibrated size ranges, and the size matters: a study comparing PVA particles of different diameters in uterine artery embolization found that starting with smaller particles (350–500 micrometers) versus larger ones (500–700 micrometers) affected how the procedure was completed, with larger particles sometimes added at the end to finish the job.¹ A separate trial comparing PVA to tris-acryl microspheres found that microspheres required higher volumes on average but caused far fewer catheter blockages during delivery, at a rate of only 4% compared with 28% for PVA.² Calibrated microspheres also appear to have a safety edge in certain brain tumor procedures: in one comparison, 400-micrometer calibrated microspheres produced a complication rate of 0% compared with about 8% for the smallest PVA particles used in an earlier cohort.³
Liquid embolics: These are injectable liquids that solidify once inside the vessel. The two main types work differently. Cyanoacrylate-based glues (often called NBCA) polymerize almost instantly on contact with blood, forming a hard cast that permanently seals the vessel. The reaction is exothermic, generating temperatures up to 80–90°C, and releases formaldehyde as a byproduct, which triggers an inflammatory response that reinforces the seal over time.⁴ The other major class, based on a polymer called ethylene vinyl alcohol copolymer (EVOH), sold under brand names like Onyx, works differently: it solidifies from the outside in, with the outer shell hardening first while the liquid interior continues to push forward, flowing in a “lava-like” pattern deeper into the blood vessel network. Unlike glue, EVOH is non-adhesive, which means there is no risk of the delivery catheter becoming permanently stuck.⁵
Coils and plugs: Metallic coils, often made of platinum or stainless steel, are pushed through the catheter and deployed in larger vessels where they coil up and slow blood flow enough for a clot to form around them. Vascular plugs work on a similar principle but are designed to block larger-caliber arteries or veins in a single deployment. These mechanical devices are commonly used in trauma settings and for sealing off abnormal connections between arteries and veins.

Whether to use a permanent or temporary agent also affects long-term outcomes. A study of bronchial artery embolization for patients coughing up blood found that permanent embolic materials provided better long-term bleeding control and lower recurrence rates compared with temporary materials, without a meaningful difference in safety.⁶

Where Embolization Is Used

The procedure’s versatility is one of its defining features. Here are the most common applications.

Uterine Fibroids

Uterine artery embolization (UAE) is one of the best-known uses. Fibroids are noncancerous growths in the uterus that can cause heavy bleeding, pain, and pressure symptoms. By blocking the arteries that feed the fibroids, embolization starves them of oxygen, causing them to shrink. The pain that follows the procedure is driven primarily by the ischemia and resulting inflammation in the uterine tissue surrounding the fibroids, not just the fibroids themselves. Larger or more numerous fibroids tend to require a heavier embolic load, which increases the degree of ischemic injury to adjacent tissue and, with it, post-procedure discomfort.⁷ Recovery after UAE averages about 13 days, with most patients spending roughly one night in the hospital.⁸

Liver Cancer

Transarterial chemoembolization (TACE) combines embolization with targeted chemotherapy for hepatocellular carcinoma, the most common type of primary liver cancer. Tiny beads or an oily contrast agent mixed with a chemotherapy drug are injected into the arteries feeding the tumor, delivering a concentrated dose of the drug while simultaneously cutting off the tumor’s blood supply. This dual mechanism, ischemia plus local drug exposure, induces tumor necrosis. Two main forms exist: conventional TACE, which uses an oily emulsion of chemotherapy and a substance called Lipiodol, and drug-eluting bead TACE, where microspheres pre-loaded with the chemotherapy agent release it slowly at the tumor site.⁹

Enlarged Prostate

Prostate artery embolization (PAE) is a newer alternative for men with benign prostatic hyperplasia (BPH), the noncancerous enlargement that makes urination difficult. By blocking the arteries that supply the prostate, the gland shrinks and urinary symptoms improve. Multiple studies now report significant improvements. One retrospective study found that symptom scores dropped by more than half and prostate volume decreased meaningfully at one year, with a substantial cut in dependence on urinary catheters.¹⁰ Another study using a glue-based embolic agent found that prostate volume dropped from an average of about 118 mL to 81 mL at the one-year mark, with similarly large symptom improvements.¹¹ PAE has shown effectiveness comparable to traditional surgical prostate resection in terms of volume reduction and symptom relief.¹²

Trauma and Emergency Bleeding

When someone arrives in the emergency department with major internal bleeding from an injury, embolization can be a faster and less invasive alternative to emergency surgery. Catheter-based embolization plays a major role in managing traumatic vascular injuries to organs like the spleen, liver, kidneys, and pelvis.¹³ Its use in patients who are hemodynamically unstable, meaning their blood pressure is dangerously low from blood loss, has been increasing as part of a broader shift toward endovascular approaches in trauma management.¹⁴

Brain Arteriovenous Malformations

Cerebral arteriovenous malformations (AVMs) are tangles of abnormal blood vessels in the brain that can rupture and bleed. Embolization is a key part of treating many of these lesions. It can occasionally be curative on its own but is more commonly used as a preparatory step before microsurgery or focused radiation therapy, reducing the size and blood flow of the AVM to make the definitive treatment safer.¹⁵

Wrist or Groin Access

The entry point for the catheter has become a significant topic in interventional radiology. Traditionally, the catheter enters through the femoral artery in the groin (transfemoral access). More recently, transradial access through the wrist has gained popularity across many embolization procedures, and the data consistently favor it for safety.

In prostatic artery embolization, a large study found that wrist access achieved technical success in about 97% of cases versus 93% through the groin. Procedure times and radiation exposure were both lower with wrist access, and access-site complications like bruising and blood clots under the skin were dramatically less common, roughly a tenth as frequent as with the groin approach.¹⁶ A multicenter study on coil embolization of unruptured brain aneurysms found that while procedural outcomes like recanalization rates were statistically identical between wrist and groin access, the rate of access-site complications was 15% with the groin versus under 2% with the wrist.¹⁷

For some procedures the advantage is less about complication rates and more about patient comfort. Groin access requires you to lie flat for hours afterward to let the puncture site seal, whereas wrist access lets you sit up almost immediately. A meta-analysis of middle meningeal artery embolization for chronic subdural hematoma found no significant differences in outcomes, hospital stay, or complications between the two routes, suggesting the choice in that setting may come down to operator comfort and patient preference.¹⁸

How Imaging Guides the Procedure

Embolization is only as good as the operator’s ability to see the vessels in real time. Standard fluoroscopy and digital subtraction angiography (DSA), which digitally removes the background anatomy to show only the contrast-filled blood vessels, form the backbone of procedural imaging.¹⁹ But in complex cases, two-dimensional images from a single angle can be ambiguous. That is where cone-beam CT has become valuable: the same C-arm X-ray machine that performs fluoroscopy rotates around you and reconstructs a three-dimensional image during the procedure itself.

A study of renal artery embolization found that cone-beam CT changed the treatment plan in more than 40% of cases, catching additional feeder vessels that standard angiography missed and clarifying mismatches between the vascular territory and the target lesion.²⁰ In bronchial artery embolization for hemoptysis, intraprocedural cone-beam CT aortography detected significantly more culprit arteries originating from unexpected locations compared with pre-procedure CT scans, and the average number of embolized vessels was higher, while procedure time actually dropped.²¹ Cone-beam CT is also used in prostatic artery embolization, where it helps identify the tiny, tortuous prostatic arteries and map nearby at-risk structures.²²

Risks and Non-Target Embolization

The most procedure-specific risk is non-target embolization, where embolic material ends up somewhere it was not supposed to go. Because the catheter is threaded deep into arterial branches that may have connections to nearby organs, skin, or muscles, stray particles or liquid agents can block blood supply to the wrong tissue. In prostatic artery embolization, one study reported a case where microspheres refluxed into an unprotected artery and caused a penile ulcer. The same study found that deliberately pre-embolizing at-risk side branches (called “protective embolization”) before delivering the main embolic load to the prostate eliminated complications related to those branches entirely.²³

In genicular artery embolization (a procedure for chronic knee pain), non-target embolization of skin and subcutaneous vessels can cause skin necrosis. A technique as simple as applying ice packs around the knee during the procedure has been shown to reduce this risk. Cooling caused the non-target blush area, the region of unintended contrast staining visible on imaging, to shrink by an average of about 74%, and patients who received cooling had significantly fewer skin changes afterward.²⁴

Other general risks include post-embolization syndrome, a cluster of symptoms including pain, low-grade fever, nausea, and fatigue that occurs as the body reacts to the tissue deprived of blood. This is most commonly discussed in the context of uterine fibroid embolization but can follow embolization of other organs as well. In rare cases, uterine embolization can lead to tissue necrosis beyond the intended fibroids, with symptoms including severe abdominal pain, fever, and abnormal discharge.⁹ These serious complications remain uncommon, but they underline the importance of careful patient selection and pre-procedure imaging.

Beyond the embolization itself, access-site complications such as bruising, hematoma, and rarely vessel damage can occur. As discussed above, wrist access has reduced these risks considerably compared with the groin approach in most procedural contexts.

What Recovery Looks Like

Recovery varies substantially depending on the target organ. For uterine fibroid embolization, the Ontario trial found that most patients spent about one night in the hospital, with pain being the most common reason for staying longer. The average recovery time before returning to normal activities was about 13 days, with a median of 10 days.⁸ This is considerably shorter than recovery from a hysterectomy or surgical myomectomy, which is part of embolization’s appeal for fibroid treatment.

For prostatic artery embolization, recovery tends to be even faster. Many men are discharged the same day and experience mild urinary symptoms such as increased frequency in the first day or two. One study reported that eight of ten patients developed temporary increased urination within 24 hours, but none had significant postoperative pain.²⁵ For trauma embolization, recovery depends entirely on the severity of the underlying injury rather than on the embolization itself.

Across all types of embolization, the small puncture site typically heals within a week or two. If you had groin access, you may be told to avoid heavy lifting for several days. Wrist access has virtually no movement restrictions once a compression band is removed, usually within a few hours.

Next-Generation Embolic Materials

Research is pushing embolic agents beyond simple vessel occlusion. Advances in material science have enabled the design of microspheres from natural polymers, synthetic polymers, and inorganic materials, each offering combinations of biodegradability, imaging visibility, and the ability to carry and release drugs.²⁶ The practical goal is an agent that blocks the vessel, delivers therapy locally, and then degrades safely once its job is done.

One example uses alginate-chitosan composite microspheres that combine high elasticity with favorable drug-loading and sustained-release characteristics, meaning they can deliver chemotherapy or other agents directly to a tumor site over an extended period.²⁷ Another line of research uses whey protein hydrogel microspheres, which can be injected through standard catheters, occlude arteries effectively, and begin to degrade over weeks. In rabbit kidney models, these microspheres remained in place for up to three weeks with signs of early degradation, and fibrous tissue anchored the residues in place, minimizing the risk of fragments migrating to other vessels.²⁸ That migration problem, where degrading microspheres break into pieces small enough to float downstream and block unintended vessels, has been one of the key obstacles with earlier biodegradable agents.

These materials are still in preclinical or early clinical stages, but the direction is clear: the future of embolization is not just about plugging a vessel but about turning the embolization site into a drug delivery platform. For cancer treatment in particular, combining the physical blockage of blood supply with sustained local chemotherapy release could amplify the effectiveness of procedures like TACE while reducing the systemic side effects that come with intravenous chemotherapy.

A Less Common Application Worth Knowing About

Partial splenic artery embolization is a procedure that gets little public attention but addresses a real clinical need. In patients with advanced liver cirrhosis, the spleen often becomes overactive and destroys platelets faster than the body can produce them, leading to dangerously low platelet counts. This makes surgeries, biopsies, and other interventions risky because the blood cannot clot properly. Partially embolizing the splenic artery reduces the spleen’s activity without removing the organ entirely. In one study, platelet counts normalized in all treated patients within a month and continued to rise through week twelve. The median duration of benefit lasted about 50 weeks. Complications occurred in roughly 42% of cases, mostly mild, with mortality remaining low at about 3%.²⁹ For patients who need their platelet counts corrected ahead of a liver transplant or another major procedure, this form of embolization can serve as a bridge that avoids the risks of surgical spleen removal.